INTRODUCTION
Homeoprotein transcription factors are encoded by a class of genes discovered on the basis of their developmental functions 1 . More recently, it was shown that several of them are also expressed in the adult, suggesting that they participate in physiological homeostasis 2, 3 .
Similarly to what has been observed during development, adult homeoprotein (HP) functions involve both cell autonomous and non-cell autonomous properties 4, 5 . Non-cell autonomous properties arise from the ability of several HPs to transfer between cells due to two highly conserved sequences present in their DNA-binding domain or homeodomain [6] [7] [8] [9] . Examples of non-cell autonomous activities in the central nervous system, include the regulation of cerebral cortex plasticity and retinal ganglion cell (RGC) survival by OTX2 [10] [11] [12] , the control of oligodendrocyte precursor cell and Cajal-Retzius cell migration by PAX6 13, 14 and the axon guidance activities of ENGRAILED-2 and VAX-1 [15] [16] [17] .
An important ENGRAILED-1 (EN1) function is to ensure the survival of mesencephalic dopaminergic (mDA) neurons of the Substantia Nigra pars compacta (SNpc). In En1 heterozygote (En1-Het) mice, mDA neurons die progressively starting at post-natal week 6
and only approximately 60% of them remain in one-year-old mice 18 . Infusion or injection of EN1 or EN2 proteins at the level of the SNpc and their internalization by mDA neurons rescues these neurons from degeneration in several Parkinson Disease mouse models [18] [19] [20] and in a primate model 21 . Following a single EN1 injection in mice, mDA rescue lasts for several weeks, a long-lasting effect reflecting that EN1, in addition to directly regulating transcription and translation 5, 22, 23 , also works as an epigenetic chromatin remodeler 20, 24 .
In the ventral spinal cord, En-1, but not En2, is expressed in V1 inhibitory interneurons [25] [26] [27] [28] [29] which form inhibitory GABAergic and glycinergic synapses on large α-motoneurons (αMNs) 30, 31 and regulate alternating flexor-extensor activity 28 32 . They contribute to the excitatory/inhibitory balance with excitatory V0 interneurons and the maintenance of this balance may be important for αMN survival 30 .
In light of our studies demonstrating that EN1, EN2 and OTX2 have pro-survival activities 5 , we investigated whether EN1 expressed by V1 interneurons may be important for αMN physiology and survival with which they are in synaptic contact. We demonstrate that En1 expression is maintained in adulthood and that En1-Het mice have early muscle weakness and abnormal spinal reflex associated with partial denervation of the neuromuscular junction (NMJ) and a later loss of large αMNs. These degenerative changes are progressive, increasing between 2 and 15.5 months of age. A single intrathecal injection of human recombinant EN1 (hEN1) at 3 months restores muscle strength, normalizes spinal reflex and NMJ innervation and promotes survival of αMNs. This restorative and protective activity lasts for at least 2 months.
MATERIALS AND METHODS

Animal Management
All animals were treated in accordance with the guideline for the care and use of laboratory animals (US National Institutes of Health), the European Directive number 86/609 (EEC Council for Animal Protection in Experimental Research and Other Scientific Utilization) and
French authorizations n° 00703.01 "Therapeutic homeoproteins in Parkinson Disease" and n° APAFIS #6034-2016071110167703 v2, "Spinal cord motoneurons neuroprotection" delivered by the Minister of higher education, research and innovation.
Adult mice were housed two to five per cage and maintained with ad libitum food and water, under a 12h light/dark cycle. Transgenic mouse strain En1-Het was bred by the Rodent Breeding Services provided by the Animal Care Services at College de France. Colony maintenance and genotyping were performed as previously described 33 . Both, females and males were included in all the studies.
Assessment of disease progression and humane end-point
Mice were considered for euthanasia if they displayed 15% loss of bodyweight or showed signs of paralysis, whichever was reached first. None of the mice were euthanized due to these reasons.
Behavioral analyses
The tests used to evaluate muscle strength and spinal reflexes are forepaw grip strength test, inverted grid test and hindlimb extension reflex. Mice were habituated to the behavioral room and experimenter 24 hours before the day of testing and again 1 hour before each behavioral test. All tests were performed the same day and behavioral assessment was carried by evaluators blind to genotype and treatment. Mice were weighed before each session. Inverted Grid Test. The mouse was placed on a wire grid (15x10 cm) and let to freely explore it. After 3-5 minutes, the grid was raised 30 cm above a soft surface and gently turned upside down. Latency to falling was recorded three times per mouse with a minimum resting time of 5 minutes between trials. The longest latency was used for further analysis.
Hindlimb Extensor Reflex. Mice were gently suspended by the tail at a constant height (30 cm) and scored for hindlimb extension reflex. The scores were assigned from 0 to 3 as follows: 3 normal symmetric extension in both hind limbs without visible tremors; 2.5 normal extension in both hind limbs with tremor in one or both paws; 2.0 unequal extension of the hind limbs without visible tremors; 1.5 unequal extension in the hind limbs with tremors in one or both paws, 1.0 extension reflex in only one hindlimb, 0.5 minimum extension of both hindlimbs, 0 absence of any hindlimb extension.
Tissue preparation
Spinal cord. Adult mice were euthanized by an overdose of Dolethal (Pentobarbital, Vétoquinol) (1μl/g body weight). The spinal cord was dissected after laminectomy and placed in PBS (20mM PO4, 155mM NaCl) to remove the meninges and surrounding connective tissue. Cervical and Lumbar enlargements were separated and placed in Paraformaldehyde 4% (PFA, Thermo Scientific) for 1 hour at room temperature with mild mixing. The tissue was then washed in PBS, three times for 30 minutes at room temperature and placed in PBS, 20% sucrose overnight at 4°C. After cryoprotection, the spinal cords were embedded in Tissue Freezing Medium (TFM, Microm Microtech), frozen on dry ice and 30μM sections prepared on an HM 560 Microm cryostat (Thermo Scientific).
Muscle. The extraocular (EOM), tongue and lumbrical muscles from the plantar surface of the paw were dissected into cold PBS and fixed at room temperature in 4% PFA for 10 minutes for extraocular and lumbrical muscles or 1 hour for the tongue. The muscles were then washed in PBS and cryoprotected. Extraocular and lumbrical muscles whole-mounts were stained to allow for visualization of the entire innervation pattern and detailed analysis of the neuromuscular junctions 34 . Tongue muscles were embedded and sectioned at 30μm. Slides with 30μM spinal cord sections were washed in PBS (1X) 3 times, cleared in O-Xylene (CARLO-HERBA) for 5 minutes, then hydrated in graded alcohols with increasing water and placed in Cresyl Violet acetate (MERCK). Sections where then dehydrated in increasing alcohols and mounted.
Cresyl violet staining.
RT-qPCR
Spinal cords were removed as above and cervical and lumbar enlargements were separated and rapidly frozen on dry ice. Total RNA was extracted (RNeasy Mini kit, Qiagen) and reverse transcribed using the QuantiTect Reverse Transcription kit (Qiagen). RT-qPCR were done using SYBR-Green (Roche Applied Science) and Light Cycler 480 (Roche Applied Science). Data were analyzed using the « 2-ddCt » method and values were normalized to 
Protein production
Human EN1 (hEN1) was produced as described 11 and endotoxins were removed by Triton X-144 phase separation 35 . In brief, pre-condensed 1% Triton X-144 (Sigma) was added to the protein preparation. The solution was incubated 30 minutes at 4°C with constant stirring, transferred to 37°C for 10 minutes and centrifuged at 4000 rpm for 10 minutes at 25°C. The endotoxin-free protein was aliquoted and kept at -20°C.
Intrathecal injections
Mice were anesthetized with ketamine (Imalgene 1000) and xylazine (Rompur 2%) in NaCl 50mM and placed on the injection platform. The tail of the animal was taken between two fingers of one hand and its back was gently flattened with the other hand. The L3 vertebral spine was identified by palpation and a 23G Lumbrical, EOM and tongue muscles were imaged with a Leica SP5 inverted confocal microscope (Leica DMI6000) with a motorized XY stage. 3D z-stack (0.5μM) acquisitions were made as indicated above (UV, Argon and DPSS) and images analyzed using ImageJ software. Analyses were performed blind to the genotype and treatment. Endplates where categorized as fully innervated (neurofilament overlying more than 80% of the endplate), partially innervated (neurofilament overlying up to 80% of the endplate) or denervated (no neurofilament overlying the endplate) 36 . Endplate morphology was evaluated by counting the number of endplates with perforations (areas lacking α-bungarotoxin staining). For postsynaptic analysis, each endplate was manually outlined using ImageJ software and area calculated. All analyses were done on the entire Z-stacks through the NMJ.
Statistical analyses
Results 
RESULTS
En1-Het mice show early and progressive motor deficits
Previous studies reported En1 expression in V1 interneurons in the early postnatal mouse spinal cord 29 . We verified that this expression is maintained at the same levels throughout life and is decreased by twofold in the En1-Het mouse both at 4.5 and 16 months, thus during the time frame of all experiments (Fig. 1a, b ). This indicates that V1 interneurons survival is preserved in the En1-Het mice, in contrast with the situation for mDA neurons of the SNpc 18 .
En1-Het mice display the same average weight gain as their WT littermates at all ages studied ( Fig. 1c ). For the three tests used to assess muscle strength, WT and En1-Het animals evolved differently, the latter showing signs of loss of strength compared to their WT littermates ( Fig.   1d -f). At one and two months of age forepaw grip strength was similar in En1-Het and WT mice, but a significant reduction was first measurable at 3 months that persisted through 15.5 months of age ( Fig. 1d ). The inverted grid test assesses the ability of the four limbs to resist gravity. Two-month-old En1-Het mice resisted significantly less than WT mice and holding time further diminished between two months and 15.5 months, revealing a progressive loss of strength ( Fig. 1e ). Finally, the hind limb extensor reflex was taken to monitor purely spinal function. WT mice had an extensor score of about three at all ages but the score of the En1-Het animals started to deteriorate overtime between 2 and 15.5 months ( Fig. 1f ). Taken together, these results show that En1-Het mice have a progressive loss of muscle strength and a deteriorating spinal reflex compared to WT siblings.
Presynaptic pathology in the neuromuscular junction of the lumbrical muscles in En1-
Het mice
Motor deficits are often accompanied by early synaptic changes at the NMJ, a specialized synapse between MN axon terminals and skeletal muscle fibers. Since NMJs are highly vulnerable from very early stages of motor disorders, we analyzed the NMJ morphology and synaptic characteristics of three muscle groups with different degrees of vulnerability in neuromuscular diseases 36 . Data corresponding to lumbrical endplates are described in Figure   2 and those corresponding to extraocular and tongue muscles in Supplemental Figure 1 .
Alpha-bungarotoxin and antibodies against neurofilament and synaptic vesicle protein 2A
were used in combination to visualize acetylcholine receptor (AChR) clusters of the motor endplate and motor axon terminals, respectively ( Fig. 2a ). The typical endplate morphology well centered on the lumbrical muscle fibers was observed in all mice examined 34 . No changes were found in the average number of AChR clusters between WT and En1-Het mice ( Fig. 2b) . The area of the motor endplate did not differ between WT and En1-Het mice throughout 9 months of age, and is significantly reduced in En1-Het mice at 15.5 months of age ( Fig. 2c ). Endplate perforations (post-junctional folds) are a region of the endplate devoid of AChR. Their number reflects the state of maturation of the NMJ and normal healthy muscles show a complex morphology with multiple perforations 37 . The percentage of endplates with perforations shows no difference between WT and En1-Het mice throughout 9 months of age ( Fig. 2d ) but is significantly reduced in the En1-Het mice at 15.5 months of age. Finally, the lumbrical NMJ innervation was evaluated. Motor endplates where categorized as fully innervated if neurofilament immunoreactivity overlaid more than 80% of the endplate. Figure 2e shows the significantly reduced NMJ innervation in En1-Het mice, starting at 3 months and worsening with age.
In contrast with lumbrical endplates, no differences between the two genotypes were observed in any of the NMJ morphological characteristics for extraocular and tongue muscles, at any age (Supp. Fig 1) .
Loss of large αMN in the En1-Het mouse spinal cord
The progressive muscle weakness of the En1-Het is paralleled with a partial denervation of the muscle fibers possibly reflecting αMN loss. We thus analyzed the number of neurons present in the cervical and lumbar enlargements of the spinal cord in the En1-Het mice and their WT littermates. At 15.5 months, the total number of Cresyl-stained neurons in the ventral spinal cord was similar for the cervical (Supp. Fig 2) and lumbar enlargements at 15.5 months ( Fig. 3a,b) . In contrast, a decrease in the number of large densely stained cells was clearly apparent in the En1-Het mouse spinal cord. To understand this, the neurons were Taken together, these results show that, compared to WT, En1-Het mice present a loss of large αMNs in the ventral spinal cord that is first apparent at 4.5 months and progresses with time, reaching about 50% at 15.5 months of age.
Recombinant hEN1 reverses the En1-Het motor phenotype, restores NMJ morphology and reduces αMN loss
Previously, we showed that exogenous HP transcription factors, including EN1, EN2 and OTX2, rescue mDA neurons and RGCs from an in vivo stress 11, 19, 20 and that this survival effect holds for several weeks following a single HP injection 11 20 . This led us to test whether a single intrathecal hEN1 injection into the spinal cord of En1-Het mice could have total or partial rescuing activities on any of the analyzed phenotypes. In the En1-Het mice muscle weakness and abnormal extensor reflex appear between 2 and 3 months ( Fig. 1 ) while αMN loss is only visible at 4.5 months ( Fig. 3e ), suggesting that three months of age is a valuable "therapeutic" window. One μg of hEN1 was injected and 24h later strong EN1 immunofluorescence was detected in the perivascular space and in neurons of lumbar spinal and cervical cord (Fig. 5a, b) . ChAT immunofluorescence showed that many of the cells that internalized hEN1 are large-sized αMNs and that the number of hEN1-stained cells was much lower in the cervical region probably due to its distance from the lumbar injection site (Fig.   5b ).
Three-month-old En1-Het and WT mice were evaluated for muscle weakness and hindlimb extensor reflex and, 2 days later, En1-Het mice were separated into two groups. A first group received 5μl of vehicle and the other 1μg of hEN1 in 5μl of vehicle without incidence on weight (Fig. 5c ). As already shown, before intrathecal injections, En1-Het mice (compared to WT siblings) had reduced forepaw grip strength, reduced time holding onto the inverted grid and had a slightly lower hind limb reflex score ( Fig. 5d-f) . One month and a half later, En1-Het mice treated with vehicle continued to do worse than WT mice in the three tests whereas the performance of hEN1 injected mice were undistinguishable from those of WT controls ( Fig. 5d-f ). Synapse morphology and αMN death were analyzed in the 4.5-old-mice injected at 3 months with vehicle or hEN1. The percentage of fully occupied endplates, reduced in En1-Het mice (Fig. 2) , returns to normal in hEN1 treated animals ( Fig. 6a) . At 3 months of age, En1-Het mice have a normal number of αMNs characterized by size and ChAT staining, but some loss has already occurred 1.5 months later (Fig. 3e ). Figure 6 (b, c) illustrates that the number of Cresyl-stained large cells and ChAT-stained large cells at the lumbar enlargement is identical at 4.5 months between WT mice and En1-Het siblings injected with hEN1 at month 3.
As a control, a mutant of hEN1 (hEN1Q50A) in which glutamine in position 50 of the homeodomain was mutated into alanine, thus allowing internalization but preventing high affinity binding to DNA 39 was also injected but showed no rescuing activity (Supp. Fig 3) .
Taken together, these experiments demonstrate that a single hEN1 injection at month 3 and at the lumbar level restores muscle strength, normalizes the spinal reflex and restores a normal NMJ morphology. In addition, the treatment blocks lumbar, but not cervical αMN degeneration, for a period of at least 1.5 months (Supp. Fig 4) . That En1-Het mouse muscle strength is restored in the forepaw grip strength and inverted grid tests suggests that the surviving αMNs in the cervical enlargement have benefited from hEN1 injection.
A single hEN1 injection at 3 months of has long-lasting effects on En1-Het mice and no effect at 9 months
To investigate if the rescue effect of a single hEN1 injection in three-month-old En1-Het mice could last more than 1.5 months, 1μg of hEN1 was injected in three-month-old En1-Het mice that were assessed weekly during the first month following injection and then monthly up to six months. Before injection, three-month-old En1-Het mice showed significant muscle weakness and an abnormal reflex compared to WT mice (Fig. 7a-c) . One week after injection the forepaw grip strength and the extensor reflex in the En1-Het mice were normalized to WT values. This improvement was fully maintained for 3 months, after which performance declined progressively to reach pre-injection levels. The improvement in the inverted grid test was more modest but followed a similar time course. When compared to 9-month-old untreated En1-Het mice, mice injected with hEN1 at 3 months and kept for 6 months did not maintain wild type values but performed better in the 3 tests than untreated age-matched En1-Het mice. At the end of the study, muscles and spinal cord tissue were dissected and analyzed. Figure 8 shows that En1-Het mice treated with hEN1 show higher NMJ innervation at 9 months than untreated age-matched En1-Het mice, although less than WT littermates (Fig.   8a ). A similar partial rescue at 9 months was also observed for  survival (Fig. 8b) . These results suggest that a single injection of hEN1 slows the degenerative processes that normally occur in the En1-Het mice.
To examine whether late administration of hEN1 would have positive effects on the En1-Het phenotype, 1μg of hEN1 or vehicle was injected in 9-month-old En1-Het mice. Before injection, En1-Het mice manifested significant reductions in forepaw grip strength, time of holding onto the inverted grid and extensor reflex score ( Fig. 7d-f ). Compared to WT siblings, vehicle and hEN1-injected En1-Het mice continued to be significantly impaired in the three tests, although, one may notice a very small improvement of the hEN1-treated En1-Het mice, two months post injection, for the forepaw grip strength and extensor reflex tests. At the end of the experiment the now 15.5-month-old mice were dissected to analyze NMJ occupancy and count the surviving MNs. As shown in Figure 8c -d, injection after 9 months had no effect on either morphological criteria evaluated at the lumbar enlargement or for hindlimb muscles.
DISCUSSION
This study establishes the importance of EN1 expression in  survival and motor strength.
It also shows that one intrathecal injection of hEN1 can rescue the En1-Het phenotype with a long-lasting activity when the injection is made before degeneration has reached a no-return point, as in 9-month-old En1-Het mice. In this study, we used the human recombinant protein, but the human and mouse proteins are 91.1% identical and were used with the same efficiency in mDA neuron survival experiments [19] [20] [21] 24 .
A day after injection hEN1 is present around vascular structures probably in the perivascular space from which it penetrates into the parenchyma and reaches the cell interior. Indeed, it has been shown before that EN1 and EN2, similarly to many HPs 5,9 translocate across the plasma membrane to reach the cell cytoplasm through a mechanism distinct of endocytosis 8 .
The examination of the ventral horns suggests a preferential accumulation in neurons, not precluding the possibility that other cells types, in particular astrocytes, also capture the protein. Among the neurons, the large neurons with a morphology evoking  are systematically more strongly labeled than the medium and small size ones. Although this requires a more detailed study, it might reveal that, physiologically, EN1 expressed by the V1 neurons is secreted and internalized by s expressing EN1-binding sites.
The latter hypothesis is in line with what was demonstrated in the case of OTX2, a HP which is specifically recognized in the cerebral cortex by a class of interneurons expressing parvalbumin 10 . OTX2 internalization is due to its recognition by glycosaminoglycans (GAG) present at the surface of these interneurons thanks to the GAG binding domain (RKQRRERTTFTRAQL) overlapping with the first helix of the homeodomain 40 .
Interestingly, similar GAG-binding domains are present upstream of the homeodomain in many HPs 3,5 , including EN1 and EN2 for which this putative GAG-binding sequence is KEDKRPRTAFTAEQL. The potential role of this domain in the specific targeting of EN1 and the presence of EN1 binding sites at the  surface will be investigated in further studies.
A striking observation is that, in the En1-Het mouse, the extensor reflex score is reduced at 2 months and muscle strength between 2 and 3 months. This corresponds to the decrease in fully occupied endplates first observed at 3 months and this precedes the loss of s observed at 4.5 months. This slight temporal discrepancy probably reflects that the s are experiencing retrograde degeneration with the terminals, thus strength, affected before cell body loss. This replicates what occurs in En1-expressing mDA neurons in the same En1-Het mouse line: their terminals show degeneration signs at 4 weeks, whereas the neurons only start dying at 6weeks of age 18, 41 . In this context, it is important to note that hEN1 injection at 3 months not only prevents  death for weeks, but also restores normal endplate morphology and muscle strength. This suggests that the neurodegenerative process is slowed or halted at least for a limited period of time since no recovery is possible after 9 months. This time limit is interesting as the time course of  degeneration is very slow with 40% of the cells still alive at 15.5 months and seems to reach a plateau. It is thus possible that s are heterogeneous in term of their dependency to EN1. This is reminiscent of the SNpc and Ventral Tegmental Area (VTA) mDA neurons, the two populations expressing En1, but the latter being more resistant to En1 hypomorphism 18 . It is also interesting to note that forelimb muscle strength was restored suggesting that even the low levels of hEN1 that attain cervical spinal cord have beneficial effects on the remaining MNs. MN-directed trophic activity 45, 46 . Finally, V1 interneurons may provide EN1 to αMNs where the protein would exert its direct protective activity as observed for OTX2 in RGCs 11 .
It is possible that EN1 protects the MNs that internalize it through one or several of the EN1-controled mechanisms that protect mDA neurons of the SNpc from oxidative stress 20, 21 .
Among these mechanisms are the regulation, through local protein translation, of Complex I mitochondrial activity 19 , DNA break repair, heterochromatin maintenance and the repression of long interspersed nuclear elements (LINE-1) expression 20, 24 . The evaluation of these possibilities will be the object of future studies.
The En1-Het mouse presents muscle weaknesses, abnormal spinal reflex, NMJ denervation and αMN loss, all phenotypes highly reminiscent of changes in Amyotrophic Lateral Sclerosis (ALS) patients and in many ALS mouse models. This raises the question as to whether the results reported here are relevant for motor neuron diseases. It is important to note that En1-Het mice do not present a number of important symptoms such as weight loss, respiratory distress, and complete paralysis or endpoint death. The absence of weight loss in the En1-Het mice may be an effect of the Swiss background mouse line. In contrast to virtually all mouse lines whose body weight asymptotes in mid-adulthood (Jackson Laboratory;
https://www.jax.org/#) both the En1-Het mice and their WT littermates continue to gain weight reaching about 80 grams at 2 years of age. Thus, it is possible that metabolic defects specific to this genetic background may mask weight losses due to αMN degeneration.
It is also possible that the extensive αMN loss up to about 60% at 15.5 months of age has little or no impact on feeding motor behaviors, although this is difficult to reconcile with the severe phenotypes observed in mouse models of ALS. ALS patients and mice in some ALS models have respiratory or cardiac failure [47] [48] [49] . We did not observe any obvious breathing difficulty in the En1-Het mice and the long-life span of the mice (at least up to two years thus far)
indicates no cardiac failure. The phrenic αMNs that drive respiration are concentrated at the C3-C4 level in mice 45 . Thus, interneuron inhibition on phrenic αMNs or αMNs themselves may be insensitive to reduced EN1. At the thoracic level that provides cardiac modulation 47, 50, 51 , inhibitory Ia interneurons are absent 52 . We did not assess the number or phrenic αMN in the thoracic spinal cord. It would be interesting to determine if the absence of phrenic and thoracic αMN loss correlates with the absence of breathing difficulties or cardiac function.
With regards to ALS patients, since all αMNs derive from the same lineage and transcription factor program, it is possible that phrenic and thoracic αMNs might respond to exogenous hEN1. 
d-f)
Nine-month-old En1-Het mice performed worse than WT mice in the three tests.
Intrathecal hEN1 injection at 9 months of age did not improve performance over the next six and a half months compared to non-treated littermates. 
